Management of inflammatory bowel disease in older persons: evolving paradigms.

about

Management of inflammatory bowel disease in older persons: evolving paradigms.

Item

http://www.wikidata.org/entity/Q55214429

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Management of inflammatory bowel disease in older persons: evolving paradigms.

@en

Management of inflammatory bowel disease in older persons: evolving paradigms.

@nl

type

Item

label

Management of inflammatory bowel disease in older persons: evolving paradigms.

@en

Management of inflammatory bowel disease in older persons: evolving paradigms.

@nl

prefLabel

Management of inflammatory bowel disease in older persons: evolving paradigms.

@en

Management of inflammatory bowel disease in older persons: evolving paradigms.

@nl

P1476

Management of inflammatory bowel disease in older persons: evolving paradigms.

@en

P2093

Jimmy K Limdi

http://www.w3.org/2001/XMLSchema#string

Saurabh Kedia

http://www.w3.org/2001/XMLSchema#string

Vineet Ahuja

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling

Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study

A practical guide to vaccinating the inflammatory bowel disease patient.

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

P304

194-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5217/IR.2018.16.2.194

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29743832

http://www.w3.org/2001/XMLSchema#string

P932

5934592

http://www.w3.org/2001/XMLSchema#string